0

Global Glioma Therapeutics Market 2019-2023

  • Published: Dec 2018
  • Pages: 121
  • SKU: IRTNTR30499
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global glioma therapeutics market size will grow by USD 861.69 million during 2019-2023. This industry research report provides a detailed analysis of the market based on product (small molecules and biologics) and geography (the Americas, APAC and EMEA). The report analyzes the market’s competitive landscape and offers information on several glioma therapeutics companies including F. Hoffmann-La Roche, Merck Sharp & Dohme, Mylan, NextSource Biotechnology and Novartis.

Below are some of the key findings from this glioma therapeutics market analysis report

 

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now! 

Global glioma therapeutics industry overview

The expected approval of late-stage pipeline molecules is driving the global glioma therapeutics market. The market is currently experiencing an acute lack of approved therapies due to non-availability of any promising treatment for glioma with minimal side effects. These late-stage pipeline molecules can tap into this unmet demand from the glioma patent pool and once these molecules are launched, the global glioma therapeutics market will witness strong growth.

Also, strategic alliances will positively impact the global glioma therapeutics market as it helps companies to develop and introduce the glioma drugs into the market at a rapid pace. The excepted approval of late-stage pipeline molecules coupled with strategic alliances is driving the glioma therapeutics market growth at a CAGR of more than 9% during the forecast period.

Top glioma therapeutics companies covered in this market research report

The global glioma therapeutics market is highly fragmented. The market is in the growth phase and the competition is expected to become more intense by the end of the forecast period. To help clients improve their revenue shares in the market, this research report provides an analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this glioma therapeutics market analysis report suggests strategies companies can follow and recommends key areas they should focus on, to make the most of upcoming growth opportunities.

The report offers a detailed analysis of several leading glioma therapeutics companies including:

  • F. Hoffmann-La Roche
  • Merck Sharp & Dohme
  • Mylan
  • NextSource Biotechnology
  • Novartis

 Glioma therapeutics market segmentation based on product

  • Small molecules
  • Biologics

Small molecules were the dominating product of the global glioma therapeutics market in 2018, owing to its high availability in the healthcare sector. The market share of this segment will continue to dominate the market throughout the next five years.

Glioma therapeutics market segmentation based on region

  • The Americas
  • APAC
  • EMEA

The Americas accounted for the largest glioma therapeutics market share in 2018, owing to the rising awareness about the disease and recent approvals of biosimilars in the region. The Americas will remain the market leader for the next five years.

Key highlights of the global glioma therapeutics market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the glioma therapeutics market during the next five years
  • Precise estimation of the global glioma therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the glioma therapeutics industry across the Americas, APAC, and EMEA
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of glioma therapeutics companies

 

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Small molecules - Market size and forecast 2018-2023
  • Biologics - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • F. Hoffmann-La Roche
  • Merck Sharp & Dohme
  • Mylan
  • NextSource Biotechnology
  • Novartis

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations


Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>